Lyophilised Powder (co-lyophilised blend)
BPC-157 + TB-500 Combination
Dual Peptide Combination — 5mg BPC-157 + 5mg TB-500 (10mg Total)
Product Description
This combination vial contains a precisely measured co-lyophilised blend of BPC-157 (Body Protection Compound 157) and TB-500 (Thymosin Beta-4 fragment), two of the most extensively studied peptides in regenerative research. Each vial delivers 5mg of BPC-157 and 5mg of TB-500, for a combined total of 10mg.
BPC-157 is a pentadecapeptide derived from a protective protein found in gastric juice. TB-500 is a synthetic version of the naturally occurring thymosin beta-4 peptide, which plays a role in actin polymerisation and cellular migration. Both peptides have been subjects of substantial preclinical research examining their roles in tissue repair, angiogenesis, and cellular recovery processes.
PeakLab Australia's combination vial is produced using pharmaceutical-grade synthesis with individual purity verification for each component prior to blending. Each order includes a Certificate of Analysis documenting the purity and identity of both peptides.
This product is supplied strictly for in vitro and laboratory research purposes only. It is not intended for human or veterinary use, and is not a therapeutic good approved by the TGA.
Research Context
BPC-157 has been investigated in numerous animal model studies examining gastrointestinal protection, tendon-to-bone healing, and neurological recovery. TB-500 research has focused on its role in promoting angiogenesis, reducing inflammation in tissue injury models, and facilitating cellular migration. The combination of these two peptides in research settings has been of interest due to their potentially complementary mechanisms of action.
